Video

Kay Verble Discusses a Study to Characterize Long-Term Survivors of GBM

Author(s):

Kay Verble

Kay Verble discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).

Kay Verble, from the Sontag Foundation and Brain Tumor Network, discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).

Rick Sontag, one of our 2015 GBM Heroes, is an entrepreneur who has worked to improve the lives of patients with GBM and other brain tumors through a multifaceted approach to engaging and supporting the brightest scientific minds in brain cancer research.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Related Content
Image of clinical trial.
July 7th 2025

New Trials Target Brain, Bladder, Ovarian and Other Cancers

Spencer Feldman
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with limited treatment paths.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
Two patients treated with Temferon have lived three years post-surgery: © stock.adobe.com.
July 2nd 2025

Temferon Linked to Long-Term Survival in Some With Glioblastoma

Spencer Feldman
Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized after initial progression.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers: © stock.adobe.com.
June 20th 2025

Clinical Trial Corner: New Treatments in Leukemia, Lymphoma and Brain Cancers

Spencer Feldman
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing safety/activity with novel therapies.
Image of brain
June 16th 2025

Explaining Brain Cancer and Metastases Updates for Patients

Ryan Scott
The 2025 ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.